Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Pharmaceutical Business Review
Return to: PBR Home
Top Headlines

Pharmaceutical Business Review

Shangai Fosun to buy 86% stake in Gland Pharma for $1.26bn China's Shangai Fosun Pharmaceutical has agreed to acquire about 86% stake in Indian drugmaker Gland Pharma for $1.26bn. Production & Manufacturing > Manufacturing > News
Oxford BioMedica secures UK MHRA approval to manufacture drugs at new facilities By PBR Staff Writer
Oxford BioMedica has secured approvals from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to manufacture bulk drug material for investigational medicinal products at its new facilities.
Production & Manufacturing > Manufacturing > News Profil Institute, HighTide Biopharmaceutical partner to develop new therapies for diabetes and NAFLD/NASH Profil Institute for Clinical Research, a science-driven clinical research organization (CRO) focused exclusively on metabolic diseases, announced today a strategic master services agreement with Shenzhen HighTide Biopharmaceutical, a subsidiary of Shenzhen Hepalink Pharmaceutical.
Contract Research & Services > Contract Services > News Sanofi wins FDA approval of Adlyxin to treat adults with type 2 diabetes Sanofi announced that the US Food and Drug Administration (FDA) approved Adlyxin (lixisenatide), a once-daily mealtime GLP-1 receptor agonist injection indicated as an adjunct to diet and exercise for the treatment of adults with type 2 diabetes.
Regulatory Affairs > News
Codexis completes obligations under research and development deal with biopharmaceutical firm Codexis has completed its obligations under a collaborative research and development agreement with a leading global biopharmaceutical company.
Contract Research & Services > Contract Research > News Pfizer, Western Oncolytics establish immuno-oncology research collaboration Pfizer and Western Oncolytics have entered into a development collaboration, license and option agreement to advance Western Oncolytics’ novel oncolytic vaccinia virus, WO-12.
Contract Research & Services > Contract Research > News GSK to invest £275m in three UK manufacturing sites By PBR Staff Writer
GlaxoSmithKline (GSK) has unveiled plans to invest £275m in its UK manufacturing network, and said that it views the country as an attractive location for investment despite last month's vote to leave the European Union.
Production & Manufacturing > Manufacturing > News

Latest News and Insight by Sector

Production & Manufacturing

Oxford BioMedica secures UK MHRA approval to manufacture drugs at new facilities
By PBR Staff Writer
Oxford BioMedica has secured approvals from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to manufacture bulk drug material for investigational medicinal products at its new facilities.
Production & Manufacturing > Manufacturing > News
GSK to invest £275m in three UK manufacturing sites
By PBR Staff Writer
GlaxoSmithKline (GSK) has unveiled plans to invest £275m in its UK manufacturing network, and said that it views the country as an attractive location for investment despite last month's vote to leave the European Union.
Production & Manufacturing > Manufacturing > News

Drug Research

Quantum Pharma launches Mucodis Rectal Gel
Quantum Pharma has launched its Mucodis Rectal Gel for the prevention and treatment of rectal mucositis, a common side effect of chemotherapy and radiotherapy in cancer patients.
Drug Research > Drug Delivery > News
Tricida raises $55m for kidney disease treatment
By PBR Staff Writer
Clinical stage, biopharmaceutical firm Tricida has raised $55m in funding for late-stage trials of its lead candidate, TRC101, in patients with kidney disease.
Drug Research > Drug Discovery & Development > News

Inward Investment

New WuXi Life Science to acquire WuXi PharmaTech for $3.3bn
Shanghai-based WuXi PharmaTech has entered into a merger agreement with New WuXi Life Science and its wholly owned subsidiary WuXi Merger, worth a total cash consideration of $3.3bn.
Inward Investment > News
PPF Group acquires minority stake in Cytune Pharma
By PBR Staff Writer
PPF Group, in cooperation with SOTIO has completed acquisition of minority stake in French biotechnology firm Cytune Pharma.
Inward Investment > News

Packaging

Catalent completes acquisition of Australia's Pharmapak
By PBR Staff Writer
US-based Catalent Pharma Solutions has strengthened its ability to provide integrated solutions to customers with the acquisition of Pharmapak Technologies, an Australian pharmaceutical packaging business.
Production & Manufacturing > OTC > News
MP Global Products introduces foam-free packaging for shipment of temperature sensitive pharmaceuticals
MP Global Thermal Packaging Products insulated protective mailers and box liners are specifically designed for temperature control and protection of mail order shipments of temperature sensitive pharma, pet meds, and natural and organic cosmetics.
Packaging > News

Contract Research & Services

Profil Institute, HighTide Biopharmaceutical partner to develop new therapies for diabetes and NAFLD/NASH
Profil Institute for Clinical Research, a science-driven clinical research organization (CRO) focused exclusively on metabolic diseases, announced today a strategic master services agreement with Shenzhen HighTide Biopharmaceutical, a subsidiary of Shenzhen Hepalink Pharmaceutical.
Contract Research & Services > Contract Services > News
Codexis completes obligations under research and development deal with biopharmaceutical firm
Codexis has completed its obligations under a collaborative research and development agreement with a leading global biopharmaceutical company.
Contract Research & Services > Contract Research > News

Automation

Synaffix achieves improved therapeutic index compared to both FDA-approved ADCs
Synaffix has completed a new set of preclinical studies that further supports the potential for its technology to enable safer and more effective targeted cancer therapeutics.
Automation > IT & Software > News
PeptiDream licenses PDPS technology to Genentech
PeptiDream has entered into a Technology License Agreement with US-based Genentech, a member of the Roche Group, to non exclusively license its Peptide Discovery Platform System (PDPS) technology.
Automation > IT & Software > News

Regulatory Affairs

Oxford BioMedica secures UK MHRA approval to manufacture drugs at new facilities
By PBR Staff Writer
Oxford BioMedica has secured approvals from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to manufacture bulk drug material for investigational medicinal products at its new facilities.
Production & Manufacturing > Manufacturing > News
Sanofi wins FDA approval of Adlyxin to treat adults with type 2 diabetes
Sanofi announced that the US Food and Drug Administration (FDA) approved Adlyxin (lixisenatide), a once-daily mealtime GLP-1 receptor agonist injection indicated as an adjunct to diet and exercise for the treatment of adults with type 2 diabetes.
Regulatory Affairs > News



Data-Label.co.uk DataLabel have been supplying
the medical industry with labels
for over 10 years

Manufactures of
healthcare packaging
machinery